Artesunate Market Size, Share & Trends by 2034

Coverage: By Type (0.99, 0.98); Form (Tablets, Injection) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00020509
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Artesunate Market Size, Share & Trends by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00020509 Email: sales@theinsightpartners.com

2025 Market Size

US$ 137.24 Mn

Base year value

2034 Forecast

US$ 275.16 Mn

Projected by 2034

CAGR 2026-2034

8.04 %

Growth rate

Addressable Market

US$ 1,854.68 Mn

(2026-2034)

The Artesunate Market size is expected to reach US$ 275.16 Million by 2034 from US$ 137.24 Million in 2025. The market is estimated to record a CAGR of 8.04% from 2026 to 2034.

The Artesunate Market report covers segmental analysis by Type (0.99, 0.98); Form (Tablets, Injection), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Artesunate Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Artesunate Market Segmentation

Type

  1. 0.99
  2. 0.98

Form

  1. Tablets
  2. Injection

Market Assessment and Insights

  • Global market for Artesunate was valued at US$ 137.24 Million in 2025
  • Annual market size is expected to reach US$ 275.16 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 1,854.68 Million
  • Market is anticipated to register a CAGR of 8.04% during the forecast period
  • The United States represents a key market, supported by Rising Malaria Incidence, Rising Awareness of Malaria Treatment Efficacy, Prevalence of Antimalarial Resistance, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Targeting Non-Malaria Endemic Regions with Prophylactic Uses, Sustainability and Ethical Sourcing of Artemisinin, Development of Long-Acting and Injectable Formulations are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including NHU, Guilin Pharma, KPC Pharmaceuticals, Nanjing Hicin Pharmaceutical, Fuyuan Pharmaceuticals, Kunming Baker Norton Pharmaceutical, MCW Healthcare, Shin Poong, Ipca Laboratories, Acino, Sanofi Aventis, Cipla, Ajanta Pharma, Amivas, Systacare Remedies, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • ● Segmentations
  • ● Geography
  • ● Competitive Analysis
  • ● Language Preferences

Artesunate Market: Strategic Insights

artesunate-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Artesunate Market Growth Drivers

  1. Rising Malaria Incidence: The Artesunate Market is significantly driven by the rising incidence of malaria worldwide. As the most effective treatment for severe malaria, Artesunate remains a cornerstone in therapeutic solutions. The ongoing fight against malaria, especially in tropical regions like Sub-Saharan Africa and Southeast Asia, boosts the demand for Artesunate injections and oral formulations. Public health initiatives that focus on malaria eradication also fuel the market's expansion.
  2. Rising Awareness of Malaria Treatment Efficacy: A growing focus on the efficacy of Artesunate in treating severe malaria is propelling its market presence. Healthcare professionals are increasingly recognizing Artesunate as the treatment of choice for uncomplicated and complicated malaria cases due to its fast action and high therapeutic success rates. The increasing awareness of its effectiveness boosts both its utilization and the demand for Artesunate across regions with high malaria burden.
  3. Prevalence of Antimalarial Resistance: The rising issue of antimalarial resistance is pushing for a continued reliance on Artesunate as an essential treatment. Artesunate's unique mechanism of action against Plasmodium falciparum, the malaria parasite, remains effective even in the face of resistance to other antimalarial drugs. This drives the ongoing demand for Artesunate, positioning it as a critical drug in the fight against resistant malaria strains.

Artesunate Market Future Trends

  1. Repositioning of Artesunate for New Indications: As research into the broader therapeutic potential of Artesunate continues to grow, its use could extend beyond malaria treatment. In the future, Artesunate may be explored for its potential in treating other conditions, such as cancer, viral infections, and parasitic diseases like schistosomiasis. The repurposing of Artesunate to target new indications is expected to drive market growth by opening new therapeutic categories and diversifying its application.
  2. Sustainability and Green Chemistry in Artesunate Production: Environmental sustainability is becoming a major trend in pharmaceutical manufacturing, including in the Artesunate Market. With increasing pressure to adopt eco-friendly practices, pharmaceutical companies are likely to invest in green chemistry solutions for the production of Artesunate. This includes reducing the environmental footprint of Artesunate synthesis and finding sustainable sourcing of raw materials, such as artemisinin, which is derived from the sweet wormwood plant. The adoption of these sustainable practices will be essential in ensuring the long-term growth and social responsibility of the Artesunate market.
  3. Enhanced Focus on Malaria Vaccine Integration: With advancements in malaria vaccine development, the Artesunate Market is expected to adapt to a more integrated malaria treatment approach. Artesunate may be combined with new malaria vaccines to form comprehensive treatment protocols that reduce both infection rates and the reliance on antimalarial drugs. This integration of vaccines and treatments like Artesunate will play a key role in tackling malaria on a global scale and could shape future market dynamics.

Artesunate Market Opportunities

  1. Targeting Non-Malaria Endemic Regions with Prophylactic Uses: An emerging opportunity in the Artesunate Market is the potential use of Artesunate in malaria prophylaxis, particularly for travelers or expatriates who visit malaria-endemic regions. As more people travel to these areas, the demand for Artesunate as a preventive treatment can rise. Pharmaceutical companies could explore developing and marketing Artesunate formulations specifically targeted toward these high-risk populations, opening a new niche in the global market.
  2. Sustainability and Ethical Sourcing of Artemisinin: As the demand for Artesunate grows, there is an opportunity for companies to lead in sustainable practices in the sourcing of artemisinin, the active ingredient in Artesunate. With rising concerns about environmental sustainability and ethical sourcing, manufacturers can capitalize on consumer and industry trends toward eco-friendly and fair-trade practices. By adopting green chemistry methods and supporting ethical sourcing of artemisinin, companies can not only differentiate their products but also strengthen their market position.
  3. Development of Long-Acting and Injectable Formulations: A promising opportunity for the Artesunate Market lies in the development of long-acting injectable formulations. These formulations would reduce the frequency of administration, improving patient adherence and making it easier to treat malaria in remote and underserved areas. The market for injectable Artesunate could expand significantly, particularly in regions where oral administration is not feasible. Developing more convenient, long-acting forms of Artesunate will also help meet the needs of patients who require more robust, long-term malaria control.

Artesunate Market Report Scope

Report Attribute Details
Market size in 2025 US$ 137.24 Million
Market Size by 2034 US$ 275.16 Million
Global CAGR (2026 - 2034) 8.04%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • 0.99
  • 0.98
By Form
  • Tablets
  • Injection
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • NHU
  • Guilin Pharma
  • KPC Pharmaceuticals
  • Nanjing Hicin Pharmaceutical
  • Fuyuan Pharmaceuticals
  • Kunming Baker Norton Pharmaceutical
  • MCW Healthcare
  • Shin Poong
  • Ipca Laboratories
  • Acino
  • Sanofi Aventis
  • Cipla
  • Ajanta Pharma
  • Amivas
  • Systacare Remedies

Artesunate Market Players Density: Understanding Its Impact on Business Dynamics

The Artesunate Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

artesunate-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Artesunate Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Artesunate Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The Artesunate Market is expected to register a CAGR of 8.04% from 2026 to 2034

The major factors impacting the Artesunate Market are: Rising Malaria Incidence, Rising Awareness of Malaria Treatment Efficacy and Prevalence of Antimalarial Resistance

Key future trends in this market are - Repositioning of Artesunate for New Indications, Sustainability and Green Chemistry in Artesunate Production and Enhanced Focus on Malaria Vaccine Integration

Key companies of this market are: NHU, Guilin Pharma, KPC Pharmaceuticals, Nanjing Hicin Pharmaceutical, Fuyuan Pharmaceuticals, Kunming Baker Norton Pharmaceutical, MCW Healthcare, Shin Poong, Ipca Laboratories, Acino, Sanofi Aventis, Cipla, Ajanta Pharma, Amivas, Systacare Remedies

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA